Bad chemical probes have messed up clinical trials for breast cancer...
At the moment the portal is populated with entries for a mere seven probes, notes William Zuercher, a chemical biologist at the University of North Carolina at Chapel Hill, and a co-author on the commentary. The portal has £50,000 (US$78,000) of seed funding from the London-based biomedical charity the Wellcome Trust, and a small group of the co-authors have pledged to curate and enter data on probes. The team hopes to hire someone to lead the project in the next few weeks. The success of the portal will depend on experts turning their frustration with inconclusive work into action, says Zuercher. “To make the resource sustainable, we will need community input.”
At any given time, almost half of all Americans are using at least one prescription drug. That’s not to mention all the over-the-counter medications we take without a prescription. ... Because of these risks, PPIs should be a last resort for heartburn. “The best place to start is by eliminating foods that might trigger the heartburn or by trying an H2 blocker,” says Macary Marciniak, PharmD, a professor at University of North Carolina’s Eshelman School of Pharmacy. H2 blockers, which work in a different way than PPIs, include over-the-counter drugs such as Pepcid and Tagamet....
With the help of a $1.8 million grant, UNC-Chapel Hill will aim to grow the workforce of scientists and doctors working in cancer nanotechnology through the launch of a new postdoctoral training program.
The five-year grant comes from the National Institutes of Health to create a postdoctoral training program within the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery. The program will be run in collaboration with the Carolina Institute for Nanomedicine, the Carolina Center for Cancer Nanotechnology Excellence and the UNC Lineberger Comprehensive Cancer Center.
Researchers (Shawn Hingtgen) at the University of North Carolina are converting skin cells into stem cells and loading them with anti-cancer drugs to use in the fight against brain tumours. Nathan Frandino reports.
By combining their strengths, three schools of pharmacy in the UK, US and Australia hope to become a voice for change within the pharmacy profession across the world.
For people with advanced diabetes, every day is a balancing act of carefully monitoring their blood sugar and responding by taking insulin through painful injections or cumbersome pumps. New technology under development in the Joint Department of Biomedical Engineering at UNC-Chapel Hill and N.C. State University could render these invasive and imprecise treatments obsolete.
Researchers in North Carolina are developing a "smart" insulin patch that can automatically detect and manage blood sugar levels, an effort they hope might one day make painful, persistent insulin injections obsolete for millions of people with diabetes.
Cristal Therapeutics announced the appointments of Prof Dr. Rob Liskamp, Prof. Dr. Twan Lammers, Prof. Dr. Alberto Gabizon, Dr. Maninder Hora and Dr. William Zamboni to its new Scientific Advisory Board.
Students in the UNC Eshelman School of Pharmacy now have an alternative way to attend classes if they cannot physically be there — a telepresence robot.
“It’s been a great benefit because without it, I don’t know that would I be able to actually finish this semester,” said Matthew Brown, a third-year student earning his doctorate of pharmacy at the school.
After Brown learned he would need cancer treatments every three weeks, he reached out to Brad Wingo, director of student affairs at the pharmacy school, and found out he could reserve the robots to virtually attend classes.
Students at the University of North Carolina (UNC) Eshelman School of Pharmacy can get by with a little help from a friend when they have to miss class.
Matthew Brown, a student earning his Doctorate of Pharmacy at the school, spoke to UNC’s The Daily Tar Heel about having to miss class due to cancer treatments every 3 weeks. After speaking with the pharmacy school’s director of student affairs, Brown learned that he could have a robot take his spot in class and then see and hear what happens inside the classroom via the robot’s videoconferencing technology.
Triangle Business Journal and accounting giant BDO unveiled its third-annual class of Life Sciences Awards winners on Wednesday.
The Life Sciences awards recognize both individuals and research organizations that are breaking ground in this field. Life sciences is a broad field that represents a number of focus areas, including biology, biotechnology, genomics, neuroscience, pharmacology and many others.
The University of North Carolina (UNC) at Chapel Hill has entered into a pharmacy alliance with Monash University in Australia and University College London (UCL).
Their partnership, PharmAlliance, which will last for at least 5 years, aims to “transform research, education, and practice in pharmacy and pharmaceutical sciences,” according to a press release from UNC’s Eshelman School of Pharmacy.
Georgia officials were indecisive about whether to proceed with a cloudy lethal injection drug, at one point saying they weren't sure whether they checked "this week's or last week's" batch, according to a court filing. ... The cloudiness could be contamination by bacteria or some impurity, said Michael Jay, a professor at the University of North Carolina's Eshelman School of Pharmacy.
Meryx Inc., a UNC-Chapel Hill spinout developing a treatment for leukemia, has raised $1.5 million.
The company is led by Stephen Frye, a UNC chemist who helped create the Center for Integrative Chemical Biology and Drug Discovery at UNC-Chapel Hill. Frye graduated from UNC in 1987 and spent 20 years at GlaxoSmithKline (NYSE: GSK) before returning to academia in 2007, according to an extensive biography on Frye by the Carolina Gazette, the university-run newsletter.
The University of North Carolina at Chapel Hill will receive $100 million for its pharmacy school, the largest individual gift in the school's history and among the top 10 donations to a college nationally in 2014.
The donation, from pharmaceutical entrepreneur and UNC alumnus Fred Eshelman, is the largest in the university's history.
The University of North Carolina at Chapel Hill on Wednesday received its largest individual donation ever, a $100 million commitment to its Eshelman School of Pharmacy.
Katie Buhlinger, a second-year student pharmacist at the University of North Carolina at Chapel Hill’s Eshelman School of Pharmacy, is having a moment in the spotlight—at least in the world of pha
Patients receiving free or low-cost medications may not stick to their prescription perfectly, but they’re not much different than patients with insurance, according to a study from the University of North Carolina at Chapel Hill.